TB-500 10mg

Sold for laboratory research use only. Not for human or veterinary use

£44.95

Research Use Only

TB-500 is a synthetic peptide corresponding to a functional fragment of Thymosin Beta-4 (Tβ4), a naturally occurring peptide involved in cellular structural regulation. It is supplied exclusively for laboratory research purposes.

In research environments, TB-500 is utilised as a model peptide compound in experimental studies examining actin-binding interactions, cellular migration processes, and peptide-mediated structural dynamics under controlled laboratory conditions. Its defined sequence and reproducible synthetic profile make it of interest in in vitro and preclinical research exploring cytoskeletal modulation and comparative peptide behaviour.

TB-500 is referenced in scientific literature as a research tool in non-clinical experimental models. Researchers may employ this peptide in controlled laboratory investigations where defined molecular structure, reproducibility, and peptide stability are required for mechanistic and structure–activity studies.

Product Information

Important Notice

This product is supplied strictly for research use only. It is not intended for human or veterinary use, and is not a medicinal product, food supplement, or cosmetic ingredient. No claims are made regarding safety, efficacy, or suitability for any therapeutic, diagnostic, or consumable application.

Batch Number: BT10/2025-04

View Certificate of Analysis:

Quick Payment

99%+ purity

Fast Delivery

WhatsApp Image 2026-01-28 at 11.18.58 PM (1)

Welcome to PeptideHub

By entering this website, you confirm that you are 18 years of age or older.

All products offered by PeptideHub are supplied strictly for laboratory and in-vitro research use only.

These products are:

  • Not for human or veterinary use
  • Not for human consumption
  • Not intended for diagnosis, treatment, cure, or prevention of disease
  • Not marketed or sold as medicinal products

 

By clicking AGREE, you confirm that you understand and accept these terms.